Atlas Trials

Phase I Study of BAY1436032 in IDH1-mutant Advanced Solid Tumors

Clinical trial NCT02746081 · COMPLETED

Trial details

NCT number
NCT02746081
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumors
Start date
2016-05-26
Primary completion
2018-11-08
Enrollment
81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.